Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharma Management Consulting ApS
APS
Active
CVR 44806975
Øverødvej 47B
Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499
Est. 2024
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 1,3M
EBITDA margin
21.1%
Equity ratio
59.4%
Financial strength
Net profit 2025
DKK 200K
1 employees
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2025
Key figures
Annual report 2025
Revenue
DKK 1,3M
—
EBITDA
DKK 269K
—
Net profit
DKK 200K
—
Total assets
DKK 404K
—
Equity
DKK 240K
—
Employees
1
—
Company information
Legal name
Pharma Management Consulting ApS
CVR number
44806975
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
2. maj 2024
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at forvalte selskabets formue, herunder passiv kapitalanbringelse. Selskabet driver ikke erhvervsmæssig virksomhed.
Contact
Address
Øverødvej 47B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other financial service activities, except insurance and pension funding n.e.c.
Companies in Rudersdal
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2025
Income statement
DKK thousands
Item
2025
Revenue
1.279
Staff expenses
-1.009
EBITDA
269
Depreciation & amort.
-0
EBIT
269
Net financials
-13
Profit before tax
257
Tax
56
Net profit
200
Balance sheet
DKK thousands
Item
2025
Total assets
404
Equity
240
Long-term debt
0
Short-term debt
164
Total debt
164
Financial ratios
5-year trend
EBITDA margin
21.1%
This company
15.8%
Market median
+34% vs market
2025
2025
Equity ratio
59.4%
This company
38.2%
Market median
+55% vs market
2025
2025
Return on equity
83.4%
This company
18.4%
Market median
+353% vs market
2025
2025
Net profit margin
15.7%
This company
8.1%
Market median
+94% vs market
2025
2025
Asset turnover
3.16×
This company
1.12×
Market median
+182% vs market
2025
2025
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-05-02 – 2025-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Jón Pétur Jónsson
Individual
100.0%
100.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pharma Management Consulting ApS also hold positions in
0
other companies.
Person
Role here
Other companies